Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:56 PM
Ignite Modification Date:
2025-12-24 @ 2:56 PM
NCT ID:
NCT06767059
Eligibility Criteria:
Inclusion Criteria:
* 18 years of age or older,
* Can read and write and speak Turkish,
* Diagnosed with primary breast cancer and know the diagnosis,
* Volunteered to participate in the research,
* Living in Ankara province,
* Paclitaxel or Paclitaxel-Transtuzumab based chemotherapy treatment initiated,
* Eastern Cooperative Oncology Group (ECOG) Scale 0 or 1,
* NCI-CTCAE v5.0 Pain, fatigue and sleep toxicity grade 1 or 2,
* You have a phone with an iOS or Android processor,
Exclusion Criteria:
* Open wounds or edema of the hands and feet,
* NCI-CTCAE v5.0 motor and sensory peripheral neuropathy with toxicity grade 3,4 or 5,
* People with a disability that would prevent them from walking,
* Diagnosed cardiovascular and pulmonary disorders,
* Diagnosed psychiatric illness,
* Communication problems,
* Bone metastases,
* Bilateral mastectomies,
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT06767059
Study Brief:
Protocol Section:
NCT06767059